Cas:423768-61-0 ethyl 4-(6-methylpyridazin-3-yl)oxybenzoate manufacturer & supplier

We serve Chemical Name:ethyl 4-(6-methylpyridazin-3-yl)oxybenzoate CAS:423768-61-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

ethyl 4-(6-methylpyridazin-3-yl)oxybenzoate

Chemical Name:ethyl 4-(6-methylpyridazin-3-yl)oxybenzoate
CAS.NO:423768-61-0
Synonyms:ethyl 4-[(6-methyl-3-pyridazinyl)oxy]benzoate;ethyl 4-[(6-methylpyridazin-3-yl)oxy]benzoate
Molecular Formula:C14H14N2O3
Molecular Weight:258.27300
HS Code:

Physical and Chemical Properties:
Melting point:70ºC
Boiling point:425.3ºC at 760 mmHg
Density:1.189g/cm3
Index of Refraction:1.559
PSA:61.31000
Exact Mass:258.10000
LogP:2.75400

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like ethyl 4-[(6-methyl-3-pyridazinyl)oxy]benzoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,ethyl 4-[(6-methylpyridazin-3-yl)oxy]benzoate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,ethyl 4-[(6-methyl-3-pyridazinyl)oxy]benzoate Use and application,ethyl 4-[(6-methyl-3-pyridazinyl)oxy]benzoate technical grade,usp/ep/jp grade.


Related News: The new rules started Saturday — however if you’re an Australian citizen, permanent resident or their immediate family, or an aircrew member who has been using appropriate protective equipment, you’re exempt. ethyl 4-(6-methylpyridazin-3-yl)oxybenzoate manufacturer It is frequently associated with the presence of blasts or leukemic cells in the marrow. ethyl 4-(6-methylpyridazin-3-yl)oxybenzoate supplier Under the sub-licensing agreement, Mankind will market the drug under its own trademark while Glenmark will manufacture and supply it to the drug firm. ethyl 4-(6-methylpyridazin-3-yl)oxybenzoate vendor The third-to-market BTK inhibitor is also looking to report top-line results from a front-line trial later this year. Imbruvica could feel more pressure if that study also turns out successful. ethyl 4-(6-methylpyridazin-3-yl)oxybenzoate factory It is frequently associated with the presence of blasts or leukemic cells in the marrow.